These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17383932)

  • 41. Comparison of the outcome in men and women with chronic heart failure.
    De Feo S; Opasich C
    Ital Heart J; 2003 Aug; 4(8):511-3. PubMed ID: 14564974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment with angiotensin converting enzyme inhibitors, angiotensin-II-antagonists and beta-blockers in an unselected group of patients with chronic heart failure.
    Watz R; Ekstrand AB; Engelbrektson V; Beermann B
    Eur J Clin Pharmacol; 2005 May; 61(3):209-14. PubMed ID: 15761755
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treatment of ischemic heart disease: Future research needs prioritization.
    Crowley MJ; Powers BJ; Myers ER; McBroom AJ; Sanders GD
    Am Heart J; 2012 May; 163(5):777-782.e8. PubMed ID: 22607854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure.
    Kuenzli A; Bucher HC; Anand I; Arutiunov G; Kum LC; McKelvie R; Afzal R; White M; Nordmann AJ
    PLoS One; 2010 Apr; 5(4):e9946. PubMed ID: 20376345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure.
    Harjola VP; Follath F; Nieminen MS; Brutsaert D; Dickstein K; Drexler H; Hochadel M; Komajda M; Lopez-Sendon JL; Ponikowski P; Tavazzi L
    Eur J Heart Fail; 2010 Mar; 12(3):239-48. PubMed ID: 20156940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The important role of angiotensin receptor blocker on treatment of chronic heart failure].
    Huang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):773-4. PubMed ID: 17217679
    [No Abstract]   [Full Text] [Related]  

  • 47. Improved outcomes in heart failure treated with high-dose ACE inhibitors and ARBs: a population-based study.
    Egiziano G; Pilote L; Behlouli H; Daskalopoulou SS
    Arch Intern Med; 2012 Sep; 172(16):1263-5. PubMed ID: 22751655
    [No Abstract]   [Full Text] [Related]  

  • 48. Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients.
    Liu CL; Shau WY; Wu CS; Lai MS
    J Hypertens; 2012 Nov; 30(11):2223-9. PubMed ID: 22929610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: what we know and current controversies.
    Moser DK; Biddle MJ
    Crit Care Nurs Clin North Am; 2003 Dec; 15(4):423-37, vii-viii. PubMed ID: 14717387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mortality and morbidity of non-systolic heart failure treated with angiotensin-converting enzyme inhibitors: a propensity-adjusted case-control study.
    Gomez-Soto FM; Romero SP; Bernal JA; Escobar MA; Puerto JL; Andrey JL; Almenara J; Gomez F
    Int J Cardiol; 2010 Mar; 139(3):276-82. PubMed ID: 19064293
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The addition of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors--what has time told us?
    Fabi MR; Teerlink JR
    Curr Heart Fail Rep; 2005 Aug; 2(2):59-64. PubMed ID: 16036052
    [TBL] [Abstract][Full Text] [Related]  

  • 52. All clinical trials are not created equal: The dilemma of HEAAL.
    Hauptman PJ
    Eur J Heart Fail; 2008 Sep; 10(9):817-8. PubMed ID: 18774334
    [No Abstract]   [Full Text] [Related]  

  • 53. [Large-scale clinical trials of patients with congestive heart failure].
    Sasayama S
    Nihon Naika Gakkai Zasshi; 1997 Dec; 86(12):2314-9. PubMed ID: 9465655
    [No Abstract]   [Full Text] [Related]  

  • 54. [Use of angiotensin type II receptor blockers as a potential strategy for chronic heart failure].
    Nakano A; Kitakaze M
    Nihon Rinsho; 2006 May; 64(5):910-6. PubMed ID: 16689373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacogenetic Risk Stratification in Angiotensin-Converting Enzyme Inhibitor-Treated Patients with Congestive Heart Failure: A Retrospective Cohort Study.
    Nelveg-Kristensen KE; Busk Madsen M; Torp-Pedersen C; Køber L; Egfjord M; Berg Rasmussen H; Riis Hansen P
    PLoS One; 2015; 10(12):e0144195. PubMed ID: 26633885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [From bench to bedside: new insights into the treatment of heart failure].
    Rengo G; Femminella GD; Liccardo D; de Lucia C; Pirozzi E; Pagano G; Mattiello G; Gargiulo P; Vitagliano A; Cirillo AP; Aruta SF; Allocca E; Leosco D; Perrone-Filardi P
    G Ital Cardiol (Rome); 2012 Apr; 13(4):254-62. PubMed ID: 22495642
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of the clinical pathway in the management of congestive heart failure.
    Ranjan A; Tarigopula L; Srivastava RK; Obasanjo OO; Obah E
    South Med J; 2003 Jul; 96(7):661-3. PubMed ID: 12940315
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
    Diav-Citrin O; Shechtman S; Halberstadt Y; Finkel-Pekarsky V; Wajnberg R; Arnon J; Di Gianantonio E; Clementi M; Ornoy A
    Reprod Toxicol; 2011 May; 31(4):540-5. PubMed ID: 21338666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The implications of a growing evidence base for drug use in elderly patients Part 2. ACE inhibitors and angiotensin receptor blockers in heart failure and high cardiovascular risk patients.
    Mangoni AA; Jackson SH
    Br J Clin Pharmacol; 2006 May; 61(5):502-12. PubMed ID: 16669842
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiotensin II receptor blockers in congestive heart failure.
    Eisenberg MJ; Gioia LC
    Cardiol Rev; 2006; 14(1):26-34. PubMed ID: 16371763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.